Use of prion conversion modulating agents

Details for Australian Patent Application No. 2009232094 (hide)

Owner Merck Serono SA

Inventors Maundrell, Kinsey; Soto-Jara, Claudio

Agent Griffith Hack

Pub. Number AU-A-2009232094

Parent 2004248302

Filing date 29 October 2009

Wipo publication date 19 November 2009

International Classifications

A61K 31/00 (2006.01)

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

G01N 33/92 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving lipids, e.g. cholesterol

Event Publications

19 November 2009 Application Open to Public Inspection

  Published as AU-A-2009232094

19 November 2009 Complete Application Filed

28 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009232105-An intrauterine system

2009232081-Novel sustainable building model